TECHNOLOGY LICENSING OPPORTUNITY: SmartBind pH Switch

Agency: ENERGY, DEPARTMENT OF
State: New Mexico
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
NAICS Category:
  • 325413 - In-Vitro Diagnostic Substance Manufacturing
Set Aside: No Set aside used
Posted Date: Nov 13, 2025
Due Date: Dec 5, 2025
Solicitation No: S-133461
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
TECHNOLOGY LICENSING OPPORTUNITY: SmartBind pH Switch
Active
Contract Opportunity
Notice ID
S-133461
Related Notice
Department/Ind. Agency
ENERGY, DEPARTMENT OF
Sub-tier
ENERGY, DEPARTMENT OF
Office
TRIAD - DOE CONTRACTOR
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Nov 13, 2025 03:06 pm MST
  • Original Response Date: Dec 05, 2025 05:00 pm MST
  • Inactive Policy: Manual
  • Original Inactive Date: Dec 05, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • NAICS Code:
    • 325413 - In-Vitro Diagnostic Substance Manufacturing
  • Place of Performance:
    Los Alamos , NM 87545
    USA
Description

This innovation from scientists at Los Alamos National Laboratory is a significant improvement on a gold standard protein purification method that gently captures and releases antibodies using mild pH changes, making antibody purification safer, more efficient, and less damaging.



The Challenge:



Purifying antibodies — vital tools in medicine and research — typically relies on a protein called Protein G that latches onto them. However, getting the antibodies back off this molecular “magnet” requires very acidic conditions, which can damage both the antibodies and Protein G itself. This harsh process risks ruining expensive materials and reducing the effectiveness of critical therapies and tests.



Problems Solved:



Researchers engineered a pH-switchable version of Protein G that uses gentle changes in acidity (pH) to control when it releases antibodies, it now binds antibodies at a mildly acidic pH and releases at a mildly basic pH — eliminating the need for harsh chemicals. This innovation protects sensitive proteins, improves efficiency, lowers costs, and opens the door for safer, greener, and more effective antibody purification in both labs and industry.



Key Advantages:




  • Gentle elution conditions: Antibodies are released at a mild pH (~8.2) instead of harsh acidic conditions (~2.7), reducing damage to both the antibodies and the protein itself.

  • Improved antibody stability and yield: Preserving antibody structure increases reliability and effectiveness, which is especially critical for therapeutic and diagnostic use.

  • Switchable binding mechanism: pH-sensitive histidine residues allow for a controlled "on/off" switch based on pH, improving process control and reproducibility.

  • Cost-effective and scalable: Reduces loss of expensive antibodies and minimizes the need for post-purification repair or replacement, saving money in industrial applications.



Market Applications:




  • Biopharmaceuticals

  • Life Sciences Research

  • Bioprocessing and Manufacturing Tools

  • Veterinary and Agricultural Biotech





Development Status: TRL 4



US Provisional / Patent No. 10,954,275



LA-UR-25-29451





LANL Tech Partnerships: Unlock the Innovative Potential



Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products.



LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov.



Note: This is not a call for external services for the development of this technology.



https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology



https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search


Attachments/Links
Contact Information
Contracting Office Address
  • 505 King Ave
  • Columbus , OH 43201
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Nov 13, 2025 03:06 pm MSTSpecial Notice (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Economic Modeling DBA Lightcast Sole Source Pre-Award $98,508 Economic Modeling DBA Lightcast Sole

New Mexico State University

Due by 9/16/2026

RFP TC FY26-27-005 Fully Insured Vision TC FY26-27-005 / 08/18/2026 TORRANCE COUNTY REQUEST

Torrance County

Due by 9/17/2026

Follow TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform Active Contract Opportunity Notice ID S-195396

ENERGY, DEPARTMENT OF

Due by 12/03/2026

Follow All in one visual acuity system Active Contract Opportunity Notice ID IHS1511834

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Due by 4/29/2029

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.